oral semaglutide efficacy and safety of once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial Oral Semaglutide Efficacy: Biomarkers &

A dual GLP-1-estrogen conjugate (GE) designed to selectively deliver estrogen to GLP-1R + cells induced substantial weight loss in mice without evidence of systemic estrogenic effects, as assessed by uterine weight and growth of estrogen-dependent breast cancer xenografts (Kanoski et al., 2011)

Refrigeration or freezer storage extends shelf life

A short pause is usually safer than pushing through severe symptoms

You still get appetite regulation, improved insulin sensitivity, and steady fat loss, but with significantly fewer side effects and a much lower risk of the muscle wasting that concerns people at higher doses

Healthcare providers can assess individual risk factors, review current medications, and provide personalized guidance